| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1085928828 |
| P356 | DOI | 10.1038/BJC.2017.165 |
| P8608 | Fatcat ID | release_qllxvj5mo5hxvl437czcim4pie |
| P932 | PMC publication ID | 5520515 |
| P698 | PubMed publication ID | 28595260 |
| P2093 | author name string | Jie Wang | |
| Jianxin Jiang | |||
| Xingjun Guo | |||
| Chencheng Xie | |||
| P2860 | cites work | KIF5B/RET fusion gene in surgically-treated adenocarcinoma of the lung. | Q50927897 |
| Proteomic analysis to identify plasma orosomucoid 2 and kinesin 18A as potential biomarkers of cholangiocarcinoma. | Q51754748 | ||
| Application of the ERK signaling pathway inhibitor PD98059 in long-term in vivo experiments. | Q54221200 | ||
| Progress in Discovery of KIF5B-RET Kinase Inhibitors for the Treatment of Non-Small-Cell Lung Cancer. | Q55068423 | ||
| An RNAi screen identifies KIF15 as a novel regulator of the endocytic trafficking of integrin | Q56990525 | ||
| Kinesin-12, a mitotic microtubule-associated motor protein, impacts axonal growth, navigation, and branching. | Q24632164 | ||
| The mitotic kinesin KIF11 is a driver of invasion, proliferation, and self-renewal in glioblastoma. | Q27324657 | ||
| The crystal structure and biochemical characterization of Kif15: a bifunctional molecular motor involved in bipolar spindle formation and neuronal development | Q27681300 | ||
| Comprehensive structural model of the mechanochemical cycle of a mitotic motor highlights molecular adaptations in the kinesin family. | Q27681421 | ||
| Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression | Q28204114 | ||
| Kinesin-12 Kif15 targets kinetochore fibers through an intrinsic two-step mechanism | Q30595517 | ||
| Kinesin-5 inhibitor resistance is driven by kinesin-12 | Q30826773 | ||
| KIF2A silencing inhibits the proliferation and migration of breast cancer cells and correlates with unfavorable prognosis in breast cancer | Q33825733 | ||
| Growth arrest signaling of the Raf/MEK/ERK pathway in cancer | Q33836237 | ||
| Kinesin family deregulation coordinated by bromodomain protein ANCCA and histone methyltransferase MLL for breast cancer cell growth, survival, and tamoxifen resistance | Q34069945 | ||
| Modulated microtubule dynamics enable Hklp2/Kif15 to assemble bipolar spindles | Q34227164 | ||
| Expression of the mitotic kinesin Kif15 in postmitotic neurons: Implications for neuronal migration and development | Q34276933 | ||
| ERK implication in cell cycle regulation | Q34594561 | ||
| Kif15 cooperates with eg5 to promote bipolar spindle assembly | Q35007385 | ||
| Kinesin family member 4A: a potential predictor for progression of human oral cancer | Q35081235 | ||
| Evaluation of KIF23 variant 1 expression and relevance as a novel prognostic factor in patients with hepatocellular carcinoma | Q35870679 | ||
| Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer. | Q36110794 | ||
| Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancer | Q36454371 | ||
| Clinicopathological relevance of kinesin family member 18A expression in invasive breast cancer | Q37204459 | ||
| Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. | Q37252144 | ||
| KIF23 is an independent prognostic biomarker in glioma, transcriptionally regulated by TCF-4. | Q37269393 | ||
| Role and regulation of kinesin-8 motors through the cell cycle | Q38241195 | ||
| Systematic review of innovative ablative therapies for the treatment of locally advanced pancreatic cancer | Q38294104 | ||
| Overexpression of integrin αv facilitates proliferation and invasion of oral squamous cell carcinoma cells via MEK/ERK signaling pathway that is activated by interaction of integrin αvβ8 with type Ⅰ collagen | Q38304434 | ||
| The Kinesin-12 Kif15 is a processive track-switching tetramer | Q38497128 | ||
| PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives | Q38710627 | ||
| An important role for Myb-MuvB and its target gene KIF23 in a mouse model of lung adenocarcinoma. | Q38769261 | ||
| Overexpression of KIF23 predicts clinical outcome in primary lung cancer patients | Q38802739 | ||
| KIF1B promotes glioma migration and invasion via cell surface localization of MT1-MMP. | Q38818997 | ||
| Kinesin 18A expression: clinical relevance to colorectal cancer progression. | Q39611073 | ||
| Molecular pathways: adaptive kinome reprogramming in response to targeted inhibition of the BRAF-MEK-ERK pathway in cancer | Q39697330 | ||
| Curcumin inhibits constitutive STAT3 phosphorylation in human pancreatic cancer cell lines and downregulation of survivin/BIRC5 gene expression | Q39745459 | ||
| Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes | Q39918833 | ||
| A unique gene having homology with the kinesin family member 18A encodes a tumour-associated antigen recognised by cytotoxic T lymphocytes from HLA-A2+ colon cancer patients | Q40413050 | ||
| Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. | Q41426806 | ||
| C-Kit Promotes Growth and Migration of Human Cardiac Progenitor Cells via the PI3K-AKT and MEK-ERK Pathways | Q41813361 | ||
| Reconstruction of an integrated genome-scale co-expression network reveals key modules involved in lung adenocarcinoma | Q43095950 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International | Q42553662 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancreatic cancer | Q212961 |
| P304 | page(s) | 245-255 | |
| P577 | publication date | 2017-06-08 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | KIF15 promotes pancreatic cancer proliferation via the MEK-ERK signalling pathway | |
| P478 | volume | 117 |
| Q100431708 | B7-H3 regulates KIF15-activated ERK1/2 pathway and contributes to radioresistance in colorectal cancer |
| Q89613632 | Development of a 15-gene signature for predicting prognosis in advanced colorectal cancer |
| Q61453962 | Distinct Diagnostic and Prognostic Values of Kinesin Family Member Genes Expression in Patients with Breast Cancer |
| Q65000057 | ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer. |
| Q90426057 | Effect of KIF22 on promoting proliferation and migration of gastric cancer cells via MAPK-ERK pathways |
| Q91928964 | Exploring the Molecular Mechanism of the Drug-Treated Breast Cancer Based on Gene Expression Microarray |
| Q97073426 | GINS2 affects cell viability, cell apoptosis, and cell cycle progression of pancreatic cancer cells via MAPK/ERK pathway |
| Q93173697 | Identification of KIF15 as a potential therapeutic target and prognostic factor for glioma |
| Q92901971 | Identification of new octamer transcription factor 1-target genes upregulated in castration-resistant prostate cancer |
| Q93047521 | Integrin beta 4 (ITGB4) and its tyrosine-1510 phosphorylation promote pancreatic tumorigenesis and regulate the MEK1-ERK1/2 signaling pathway |
| Q97543664 | KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors |
| Q89929998 | KIF15 Expression in Tumor-associated Monocytes Is a Prognostic Biomarker in Hepatocellular Carcinoma |
| Q92134426 | KIF15 Promotes Proliferation and Growth of Hepatocellular Carcinoma |
| Q93164713 | KIF15 facilitates gastric cancer via enhancing proliferation, inhibiting apoptosis, and predict poor prognosis |
| Q64099522 | KIF15 promotes bladder cancer proliferation via the MEK-ERK signaling pathway |
| Q55073830 | KIF4A facilitates cell proliferation via induction of p21-mediated cell cycle progression and promotes metastasis in colorectal cancer. |
| Q92241114 | KIF5A Promotes Bladder Cancer Proliferation In Vitro and In Vivo |
| Q64113663 | LAMB3 mediates apoptotic, proliferative, invasive, and metastatic behaviors in pancreatic cancer by regulating the PI3K/Akt signaling pathway |
| Q60916561 | Mutations Defining Patient Cohorts With Elevated PD-L1 Expression in Gastric Cancer |
| Q58796673 | SPARCL1 suppresses the proliferation and migration of human ovarian cancer cells via the MEK/ERK signaling |
| Q64910335 | m6A methyltransferase METTL3 suppresses colorectal cancer proliferation and migration through p38/ERK pathways. |
Search more.